Literature DB >> 33659960

An overview of the treatment of cutaneous leishmaniasis.

Talissa F Garza-Tovar1, Marco I Sacriste-Hernández1, Eder R Juárez-Durán2, Roberto Arenas2.   

Abstract

Leishmaniasis is a neglected tropical disease caused by species of Leishmania, with a broad spectrum of clinical manifestations, such as cutaneous, visceral, and mucocutaneous presentations. Many drugs are used for its treatment, and a current effective one is a pentavalent antimonial, especially in developing countries. In this review, we discuss recent proposed therapies as well as their side effects. Copyright:
© 2020 Arenas R et al.

Entities:  

Keywords:  Antimonials; Leishmaniasis; Treatment

Year:  2020        PMID： 33659960      PMCID： PMC7886081          DOI： 10.12703/r/9-28

Source DB:  PubMed          Journal:  Fac Rev        ISSN： 2732-432X


  3 in total

1.  Nanomedicine-based strategies to improve treatment of cutaneous leishmaniasis.

Authors:  Nowsheen Goonoo; Marie Andrea Laetitia Huët; Itisha Chummun; Nancy Karuri; Kingsley Badu; Fanny Gimié; Jonas Bergrath; Margit Schulze; Mareike Müller; Archana Bhaw-Luximon
Journal:  R Soc Open Sci       Date:  2022-06-15       Impact factor: 3.653

2.  A case of a verrucous and pseudotumoral mass on the leg that resolved with cryotherapy.

Authors:  Mariem Rekik; Khadija Sellami; Mariem Amouri; Saadia Makni; Naourez Gouiaa; Tahya Boudaouara; Hamida Turki
Journal:  Clin Case Rep       Date:  2022-02-01

Review 3.  Current and future strategies against cutaneous parasites.

Authors:  Ernest Man; Helen P Price; Clare Hoskins
Journal:  Pharm Res       Date:  2022-03-21       Impact factor: 4.580
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.